Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.740
0.00 (0.00%)
Sep 5, 2025, 4:00 PM - Market closed
Pulmonx Stock Forecast
Stock Price Forecast
The 7 analysts that cover Pulmonx stock have a consensus rating of "Buy" and an average price target of $7.66, which forecasts a 340.23% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $16.
Price Target: $7.66 (+340.23%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 1, 2025.
Analyst Ratings
The average analyst rating for Pulmonx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +72.41% | Aug 1, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +359.77% | Jul 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $5 | Strong Buy | Maintains | $16 → $5 | +187.36% | Jul 31, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $9 → $2.5 | Buy → Hold | Downgrades | $9 → $2.5 | +43.68% | Jul 31, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +819.54% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
92.42M
from 83.79M
Increased by 10.30%
Revenue Next Year
106.03M
from 92.42M
Increased by 14.72%
EPS This Year
-1.57
from -1.44
EPS Next Year
-1.40
from -1.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 96.4M | 124.2M | |||
| Avg | 92.4M | 106.0M | |||
| Low | 88.2M | 97.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 34.3% | |||
| Avg | 10.3% | 14.7% | |||
| Low | 5.3% | 5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.58 | -1.21 | |||
| Avg | -1.57 | -1.40 | |||
| Low | -1.57 | -1.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.